(Q29036235)

https://doi.org/10.1016%2FS0079-6123%2802%2939016-2

27 March 2017

0 references

1 reference

M. Thibonnier

1

1 reference

https://doi.org/10.1016%2FS0079-6123%2802%2939016-2

27 March 2017

P. Coles

series ordinal

2

1 reference

https://doi.org/10.1016%2FS0079-6123%2802%2939016-2

27 March 2017

A. Thibonnier

series ordinal

3

1 reference

https://doi.org/10.1016%2FS0079-6123%2802%2939016-2

27 March 2017

M. Shoham

series ordinal

4

1 reference

https://doi.org/10.1016%2FS0079-6123%2802%2939016-2

27 March 2017

language of work or name

1 reference

2002

1 reference

https://doi.org/10.1016%2FS0079-6123%2802%2939016-2

Progress in Brain Research

27 March 2017

published in

1 reference

https://doi.org/10.1016%2FS0079-6123%2802%2939016-2

27 March 2017

page(s)

179-196

1 reference

https://doi.org/10.1016%2FS0079-6123%2802%2939016-2

The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor

27 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

A Conserved NPLFY Sequence Contributes to Agonist Binding and Signal Transduction but Is Not an Internalization Signal for the Type 1 Angiotensin II Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Transient phosphorylation of the V1a vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Accurate modeling of protein conformation by automatic segment matching

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Regulation of tyrosine kinase cascades by G-protein-coupled receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Synthetic rat V1a vasopressin receptor fragments interfere with vasopressin binding via specific interaction with the receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Crystal structure of rhodopsin: A G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

G protein-coupled receptor kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Molecular docking using surface complementarity.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Signal transduction of V1-vascular vasopressin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

An extracellular residue determines the agonist specificity of V2 vasopressin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

WHAT IF: a molecular modeling and drug design program

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

Molecular pharmacology of human vasopressin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2802%2939016-2

7 January 2021

10.1016/S0079-6123(02)39016-2

Identifiers

DOI

1 reference

https://doi.org/10.1016%2FS0079-6123%2802%2939016-2